We employ rigorous science

to pioneer the discovery and clinical development of the next generation of naturally derived bioactives, starting with Mitopure™ (a proprietary highly pure Urolithin A). Our focus is the development of innovative products designed to meet the health needs of an aging population. Our current work builds on modulating Mitochondrial function.

We are improving muscle health

Our most advanced product targets the reversal of age-related muscle decline by improving the activity of mitochondria – the “powerhouse of the cell” – to optimize muscle function.

Society is aging. Worldwide,
it’s projected there will be more than 1 billion people over 65 years old by 2030. 

A decline in skeletal muscle strength and overall function is a hallmark of aging. These changes can become debilitating and lead to a condition called sarcopenia, which is thought to affect 30% of elderly.

We are targeting a novel pathway

Our lead bioactive - a metabolite of pomegranates - has been demonstrated to trigger a highly effective biological mechanism of action that recycles and rejuvenates aging mitochondria via a process called mitophagy.

Our leadership

Includes world class scientists and medical professionals.
Our board features leading members of the Life Science and Pharmaceutical industries.

 Amazentis Announces the Launch of Timeline™ Cellular Nutrition at the World Economic Forum in Davos 

​

Amazentis  l  Press Release  l  January 23rd 2020

First Human Clinical Trial Results on the Anti-Aging Compound, Urolithin A, Published by Amazentis and Researchers from the EPFL and SIB

​

Amazentis  l  Press Release  l  June 14th 2019

Nestlé Health Science invests in global strategic partnership with Amazentis to develop its new cellular nutrient Urolithin A

​

Amazentis  l  Press Release  l  April 2nd 2019

Amazentis SA Announces Completion of Series C Financing

Amazentis Also Announces Initiation of Two Pivotal, Phase 2 Clinical Studies in North America

​

Amazentis  l  Press Release  l  March 21st 2018

Amazentis SA Announces Successful Phase 1A/1B Study Results in Healthy Elderly Subjects with the Food Metabolite Urolithin A

​

Amazentis  l  Press Release  l  April 27th 2017

Milestone Study on Pomegranate Anti-Aging Mechanism Reported

by Amazentis SA and EPFL Researchers

​

Amazentis  l  Press Release  l  July 11th 2016

Pomegranate finally reveals its powerful anti-aging secret /

La grenade révèle une puissante molécule anti-vieillissement

​

EPFL  l  Press Release  l  July 11th 2016

Pomegranates reveal its powerful anti-aging secret

EPFL  l  Video  l  July 6th 2016

Pomegranate compound with anti-aging effects passes human trial

​

medicalxpress  l  Published online  l  June 17th 2019

The mitophagy activator urolithin A is safe and induces a molecular signature of improved mitochondrial and cellular health in humans

​

Nature Metabolism  l  Published online  l  June 14th 2019

Nestle Deal Seeks to Tap Pomegranate's Anti-Aging Potential

​

Bloomberg  l  Published online  l  April 2nd 2019

Urolithin A induces mitophagy and prolongs lifespan in C. elegans and increases muscle function in rodents

​

Nature Medicine  l  Published online  l  July 11th 2016

Pomegranate by-product boosts muscles and may fight ageing

​

New Scientist  l  Published online  l  July 11th 2016

 Gut bacteria unleash anti-aging power of pomegranates 

​

Medical News Today  l  Published online  l  July 11th 2016

 Discovery of pomegranate's anti-ageing molecule is a 'milestone' 

​

Telegraph  l  Published online  l  July 11th 2016

Amazentis va commercialiser la «vitamine C» de l’anti-âge

​

Bilan  l  Published online  l  July 11th 2016

Pomegranate by-product boosts muscles and may fight ageing

​

Financial Times  l  Published online  l  July 12th 2016

 Pomegranate could help you live longer 

​

The Times  l  Published online  l  July 12th 2016

Pomegranates Yield Promising Anti-Aging Compound

​

Gizmodo  l  Published online  l  July 12th 2016

 Granadas contra el envejecimiento muscular 

​

El Pais  l  Published online  l  July 12th 2016

A molecule to fight ageing

​

Swissquote  l  Published online  l  January 2017

 Amazentis Launches Timeline™ powered by Mitopure™
A Breakthrough in Cellular Nutrition 

​

Amazentis  l  Press Release  l  July 27th 2020

 Amazentis Announces the Launch of Timeline™ Cellular Nutrition at the World Economic Forum in Davos 

​

Amazentis  l  Press Release  l  January 23rd 2020

First Human Clinical Trial Results on the Anti-Aging Compound, Urolithin A, Published by Amazentis and Researchers from the EPFL and SIB

​

Amazentis  l  Press Release  l  June 14th 2019

Nestlé Health Science invests in global strategic partnership with Amazentis to develop its new cellular nutrient Urolithin A

​

Amazentis  l  Press Release  l  April 2nd 2019

Amazentis SA Announces Completion of Series C Financing

Amazentis Also Announces Initiation of Two Pivotal, Phase 2 Clinical Studies in North America

​

Amazentis  l  Press Release  l  March 21st 2018

Amazentis SA Announces Successful Phase 1A/1B Study Results in Healthy Elderly Subjects with the Food Metabolite Urolithin A

​

Amazentis  l  Press Release  l  April 27th 2017

Milestone Study on Pomegranate Anti-Aging Mechanism Reported

by Amazentis SA and EPFL Researchers

​

Amazentis  l  Press Release  l  July 11th 2016

Pomegranate finally reveals its powerful anti-aging secret /

La grenade révèle une puissante molécule anti-vieillissement

​

EPFL  l  Press Release  l  July 11th 2016

Pomegranates reveal its powerful anti-aging secret

EPFL  l  Video  l  July 6th 2016